Breaking News
Investing Pro 0
Cyber Monday SALE: Up to 54% OFF InvestingPro+ CLAIM OFFER
Close

Pfizer Inc BDR (PFIZ34)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
66.99 +2.20    +3.40%
25/11 - Closed. Currency in BRL ( Disclaimer )
  • Volume: 9,280
  • Bid/Ask: 66.09 / 67.00
  • Day's Range: 64.79 - 66.99
Type:  Equity
Market:  Brazil
ISIN:  BRPFIZBDR006 
Pfizer Inc BDR 66.99 +2.20 +3.40%

PFIZ34 Financial Summary

 
See below for an overview of the Pfizer Inc BDR financial reports. To explore the data further, select a tab to navigate onto a specific report page. Choose to view either annual or quarterly report data.

Pfizer Inc. reported earnings results for the third quarter and nine months ended October 02, 2022. For the third quarter, the company reported sales was USD 22,638 million compared to USD 24,035 million a year ago. Net income was USD 8,608 million compared to USD 8,146 million a year ago. Basic earnings per share from continuing operations was USD 1.54 compared to USD 1.45 a year ago. Diluted earnings per share from continuing operations was USD 1.51 compared to USD 1.43 a year ago. Basic earnings per share was USD 1.54 compared to USD 1.45 a year ago. Diluted earnings per share was USD 1.51 compared to USD 1.42 a year ago.For the nine months, sales was USD 76,040 million compared to USD 57,450 million a year ago. Net income was USD 26,378 million compared to USD 18,586 million a year ago. Basic earnings per share from continuing operations was USD 4.7 compared to USD 3.37 a year ago. Diluted earnings per share from continuing operations was USD 4.6 compared to USD 3.31 a year ago. Basic earnings per share was USD 4.71 compared to USD 3.32 a year ago. Diluted earnings per share was USD 4.6 compared to USD 3.27 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

PFIZ34 Income Statement

Gross margin TTM 66.16%
Operating margin TTM 39.9%
Net Profit margin TTM 29.81%
Return on Investment TTM 27.6%
 Total Revenue  Net Income
Period Ending: Oct 02, 2022 Jul 03, 2022 Apr 03, 2022 Dec 31, 2021
Total Revenue 22638 27742 25661
Gross Profit 16604 19572 15707
Operating Income 10150 12739 10352
Net Income 8608 9906 7864

PFIZ34 Balance Sheet

Quick Ratio MRQ 1.18
Current Ratio MRQ 1.59
LT Debt to Equity MRQ -
Total Debt to Equity MRQ 39.94%
 Total Assets  Total Liabilities
Period Ending: Oct 02, 2022 Jul 03, 2022 Apr 03, 2022 Dec 31, 2021
Total Assets 195350 195290 183841 181476
Total Liabilities 102460 107821 101156 104013
Total Equity 92890 87469

PFIZ34 Cash Flow Statement

Cash Flow/Share TTM -
Revenue/Share TTM -
Operating Cash Flow  13.48%
 Cash  Net Change in Cash
Period Ending: Oct 02, 2022 Jul 03, 2022 Apr 03, 2022 Dec 31, 2021
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 5974 6541
Cash From Investing Activities -627 567
Cash From Financing Activities -5761 -6578
Net Change in Cash -487 529
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

PFIZ34 Comments

Write your thoughts about Pfizer Inc BDR
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email